GSK plc
GSK.LFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
39,220
Cost of Revenue
11,845
Gross Profit
27,375
Gross Margin
69.8%
Operating Income
7,078
Operating Margin
18.0%
Net Income
3,219
Net Margin
8.2%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
8,344
EBITDA Margin
21.3%
2023
12/31/2023
Revenue
37,910
Cost of Revenue
11,345
Gross Profit
26,565
Gross Margin
70.1%
Operating Income
8,741
Operating Margin
23.1%
Net Income
6,160
Net Margin
16.2%
EPS (Basic)
$2.00
EPS (Diluted)
$1.00
EBITDA
11,423
EBITDA Margin
30.1%
2022
12/31/2022
Revenue
36,655
Cost of Revenue
12,328
Gross Profit
24,328
Gross Margin
66.4%
Operating Income
8,353
Operating Margin
22.8%
Net Income
18,695
Net Margin
51.0%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
10,786
EBITDA Margin
29.4%
2021
12/31/2021
Revenue
30,870
Cost of Revenue
10,441
Gross Profit
20,429
Gross Margin
66.2%
Operating Income
6,756
Operating Margin
21.9%
Net Income
5,481
Net Margin
17.8%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
8,066
EBITDA Margin
26.1%
2020
12/31/2020
Revenue
42,624
Cost of Revenue
13,720
Gross Profit
28,904
Gross Margin
67.8%
Operating Income
10,229
Operating Margin
24.0%
Net Income
7,186
Net Margin
16.9%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
12,703
EBITDA Margin
29.8%